Public Company News
Clinical Trial Application of ASC40 Combined with Bevacizumab to Treat Patients with Recurrent Glioblastoma Accepted by China NMPA
HANGZHOU and SHAOXING, China, May 25, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that following the consultation with China National Medical Products Administration (NMPA), the clinical trial application of ASC40 combined with bevacizumab to treat patients with re...
2021-05-25 08:30
3826
Innovent Announces First Patient Dosed in China in the Global Phase 3 Clinical Trial of Pemigatinib as the First-line Treatment of Unresectable or Metastatic Cholangiocarcinoma
SAN FRANCISCO and SUZHOU, China, May 25, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dis...
2021-05-25 08:00
12138
Antengene Appoints Kathryn Gregory as Vice President and Head of Corporate Business Development
SHANGHAI and HARTFORD, Conn., May 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and...
2021-05-25 08:00
4880
CLPS Incorporation Announces Strategic Cooperation with MCT, a Hong Kong Listed Company, to Develop a Next Generation Loan Trading Software
HONG KONG, May 24, 2021 /PRNewswire/ -- CLPS Incorporation (Nasdaq: CLPS) ("CLPS" or "the Company"), today announced a strategic cooperation with Minshang Creative Technology Holdings Limited ("MCT", 01632.HK) to jointly develop a next generation loan trading software and to explore global financ...
2021-05-24 20:30
7318
Biovaxys Strengthens Internal Expertise With Appointment Of Scientific Advisor For Ovarian Cancer Vaccine Clinical Program And Papilocare Marketing
VANCOUVER, British Columbia, May 24, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA: 5LB, US OTCQB: BVAXF) ("BioVaxys" or "the Company") is pleased to announce thatCharles J. Dunton, MD, has joined BioVaxys as an Advisor to help provide additional scientific support for BVX-0918A,...
2021-05-24 20:00
7950
Ping An Supports Global Poverty Alleviation, Taking Successful China Handicraft Project to Cambodia
HONG KONG and SHANGHAI, May 24, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318; SSE: 601318) announced a new poverty alleviation program forCambodia at the International Forum on Poverty Governance and Development Towards Moder...
2021-05-24 19:34
15399
Akeso's Penpulimab Monoclonal Antibody Submitted BLA in the United States
HONG KONG, May 24, 2021 /PRNewswire/ -- On May 24, 2021, Akeso, Inc. (HKEx: 9926.HK) announced that Penpulimab (research and development code: AK105), an PD-1 monoclonal antibody drug co-developed by the Company with Sino Biopharmaceutical Limited (HKEx: 1177.HK), has submitted a Biologics Licens...
2021-05-24 18:17
3665
CanSinoBIO Receives European GMP Certification for its COVID-19 Vaccine Convidecia™
* A major step for introducing Convidecia™ to more countries and people in need for protection * Vaccine has been approved in China, Mexico, Pakistan, Hungary and Chile * Provides timely clinical protection for adults aged 18 and above, including those over 60 TIANJIN, China, May 24, 2021 /P...
2021-05-24 17:00
6722
Daewoong, first-in-class PRS-inhibitor for Idiopathic Pulmonary Fibrosis (IPF) shows promising result in early stage clinical test
* We confirmed the safety of 'DWN12088' and secured grounds for establishing treatment dosage * Confirming the potential as a treatment for IPF and planning to apply for Ph.2 within 2021 * 2nd ODD granted as treatment for systemic sclerosis from the US FDA SEOUL, South Korea, May 24, 2021 /...
2021-05-24 16:59
2251
Kuaishou Technology Announces First Quarter 2021 Unaudited Financial Results
HONG KONG, May 24, 2021 /PRNewswire/ -- Kuaishou Technology (HK:1024) (the "Company" or "Kuaishou"), a leading content community and social platform, today announced its unaudited consolidated results for the first quarter of 2021 endedMarch 31, 2021 ("1Q2021"). First Quarter 2021 Key Financial ...
2021-05-24 16:50
14242
Sonata Software celebrates 30 years of relationship with Microsoft
- To further expand the relationship with a range of new growth initiatives and investments aligned to Microsoft strategy BANGALORE, India, May 24, 2021 /PRNewswire/ -- Sonata Software Ltd., a global IT services and technology solutions company, announced 30 years of relationship with Microsoft,...
2021-05-24 16:20
5982
Ericsson updates risk factors for Euro corporate bond prospectus
STOCKHOLM, May 24, 2021 /PRNewswire/ -- As previously disclosed by Ericsson (NASDAQ: ERIC) in its Q4 2020 financial report and in its 2020 annual report, there is a risk that the decision by the Post and Telecommunication Authority (PTS) to exclude Chinese vendors' products from the 5G auction in...
2021-05-24 15:21
5617
iQIYI Launches its "SWEET ON Theater" Romantic Drama Collection
BEIJING, May 24, 2021 /PRNewswire/ -- iQIYI Inc. (NASDAQ: IQ) ("iQIYI" or the "Company"), an innovative market-leading online entertainment service inChina, is pleased to announce that it has released the first series of its "SWEET ON Theater", a new collection of romantic dramas. The first serie...
2021-05-24 14:45
6116
Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID
SEOUL, Korea, May 24, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a biotechnology firm specializing in molecular diagnostics has once again been recognized for its unique system for diagnosing COVID-19 variants at this year's European Congress of Clinical Microbiology, the ECCMID. Seegene's...
2021-05-24 09:58
2280
Payment security is key as Asia Pacific resets digital commerce in post-pandemic world
SINGAPORE, May 24, 2021 /PRNewswire/ -- Visa, the leader in digital payments, has set its focus on strengthening payments security as consumer behaviour evolves during the pandemic. Addressing more than 1,500 partners and clients in its first virtual edition of the Asia Pacific Visa Security Summ...
2021-05-24 09:10
8227
Poster to Highlight ENVASARC Pivotal Trial of Envafolimab (KN035) will be presented at the 2021 ASCO Annual Meeting
SUZHOU, China, May 24, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced the study design of the ENVASARC pivotal trial in the U.S. of Envafolimab (KN035), a recombinant humanized PD-L1 single domain antibody independently invented by Alphamab Oncology, will be presented by A...
2021-05-24 08:54
6681
Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea
Novavax and SK bioscience reaffirm partnership during meeting with South Korean leaders GAITHERSBURG, Md., May 23, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the signing of a non-...
2021-05-23 00:39
10083
Ortho Clinical Diagnostics Simultaneously Launches First Quantitative COVID-19 IgG Spike Antibody Test As Well As A Nucleocapsid Antibody Test to Help Differentiate Cause of Antibody Response
- Ortho is the only company that offers laboratories in the U.S. a quantitative test in combination with a nucleocapsid test - Both new antibody tests help health care teams differentiate the cause of antibodies against SARS-CoV-2 - Ortho's new VITROS® Anti-SARS-CoV-2 IgG Quantitative Antibody t...
2021-05-22 05:22
9941
Royal Canadian Mint Reports Profits and Performance for Q1 2021
OTTAWA, ON, May 22, 2021 /PRNewswire/ -- The Royal Canadian Mint (the "Mint") is pleased to announce its financial results for the first quarter of 2021 that provide insight into our activities, the markets influencing our businesses and our expectations for the next 12 months. "The Mint's stron...
2021-05-22 02:19
9014
Interactive Events To Raise Funds for the Fight Against Childhood Cancer
STOCKHOLM, May 21, 2021 /PRNewswire/ -- Cupcake-making, trail-running races, dog training, and a three-hour live meditation are among the events scheduled during the Week of Hope by Bambuser. From 24-30 May, anyone can arrange almost anything to support the fight against childhood cancer. Even be...
2021-05-21 21:18
11931
Week's Top Stories
Most Reposted
Visa Destinations Launches in Asia Pacific as Regional Travel Remains Resilient
[Picked up by 329 media titles]
2026-05-05 10:01Agoda Makes it Easier for Travelers to See Relevant Photos in Reviews
[Picked up by 311 media titles]
2026-05-06 12:00
AVPN AI Opportunity Fund Expands to Build AI-Ready Generations Across Asia by Empowering Educators and Youth Across Asia-Pacific
[Picked up by 296 media titles]
2026-05-05 09:00Colebrook Bosson Saunders Expands Flo X Multi Compatibility for Curved Ultrawide Monitors
[Picked up by 288 media titles]
2026-05-05 11:00
MetaOptics - Update on Proposed Nasdaq Dual Listing
[Picked up by 282 media titles]
2026-05-05 08:00Most Read
DMALL Gains Momentum in Southeast Asia with AI-Driven Retail Platform
2026-05-04 13:33
6717
Blaize and Winmate Sign Strategic Partnership Agreement to Bring AI to Rugged Systems for Defense and Critical Infrastructure
2026-05-04 19:00
6454
Visa Destinations Launches in Asia Pacific as Regional Travel Remains Resilient
2026-05-05 10:01
6453
